Results 251 to 260 of about 13,340,828 (402)
Genetic and Metabolic Disease in Paediatrics [PDF]
, 1986 Lindsey I. Sinclair
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Gene therapy for genetic diseases: challenges and future directions. [PDF]
MedComm (2020)Qie B, Tuo J, Chen F, Ding H, Lyu L.
europepmc +1 more source
Advance in Genomics of Rare Genetic Diseases. [PDF]
Biomolecules, 2023 Sommariva E, Bellin M, Di Resta C.
europepmc +1 more source
Genetic engineering and foot and mouth disease vaccines [PDF]
, 1981 J. B. Brooksby
openalex +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
Next-generation sequencing (NGS) techniques for pre-symptomatic identification of genetic diseases in newborns. [PDF]
Cochrane Database Syst RevPessano S +6 more
europepmc +1 more source